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Abstract: Leptin is one of the main adipokines secreted in breast tissue, and has been 
associated with epithelial-mesenchymal transition (EMT) and tumor progression in breast 
cancer. Leptin promotes EMT, cell migration and invasion in epithelial breast cells, leading 
to tumor progression. However, the molecular mechanism that underlies these events is not 
fully understood; however, the activation of different signaling pathways appears to be 
essential. In this sense, the effect of leptin on the activation of kinases like Src and FAK, 
which regulate signaling pathways that activate the EMT program, has not been completely 
described. Therefore, we investigated the involvement of these kinases using an in vitro 
model for leptin-induced EMT process in the non-tumorigenic MCF10A cell line. To this 
end, MCF10A cells were stimulated with leptin, and Src and FAK activation was assessed. 
Specific events occurring during EMT were also evaluated in the presence or absence of the 
kinases’s chemical inhibitors PP2 and PF-573228. For instance, we tested the expression 
and subcellular localization of the EMT- -catenin, 
by western blot and immunofluorescence. We also evaluated the secretion and activation of 
matrix metalloproteases (MMP-2 and MMP-9) by gelatin zymography. Invasiveness 
properties of leptin-stimulated cells were determined by invadopodia formation assays, and 
by the transwell chamber method. Our results showed that leptin promotes EMT through 
Src and FAK activation, which leads to the secretion and activation of MMP-2 and MMP-
9, invadopodia formation and cell invasion in MCF10A cells. In conclusion, our data 
suggest that -catenin, the 
secretion of MMP-2, MMP-9, the invadopodia formation and invasion in MCF10A cells in 
a Src and FAK-dependent manner. 
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1. Introduction 
Leptin is a 16 kDa hormone secreted mainly by adipose tissue, and in lesser extent by the 
placenta, stomach, fibroblasts, skeletal muscle, normal and tumorigenic mammary epithelial 
tissue [1]. Leptin plays an important role in the regulation of energy homeostasis, endocrine 
and immune functions, as well as in lipid and glycolytic metabolism [2,3]. The 
overexpression of leptin and its receptor, the ObR, has been associated to tumor progression-
related events in breast cancer [4–6]. Leptin exerts its effects through binding with the ObR 
receptor, promoting the activation of several signaling pathways such as MAPK, PI3K/AKT 
and JAK/STAT [3,7,8]. The signaling pathways activated by leptin regulate cell proliferation, 
migration, invasion and epithelial-mesenchymal transition (EMT) [4,5,9–11].  
The EMT is a reversible cellular trans-differentiation program from epithelial to a 
mesenchymal phenotype, which provides greater plasticity and dynamism to the cells [3,12–
14]. EMT is a physiological process necessary for embryonic development, wound healing 
and tissue regeneration; however, it is also associated with cancer progression [12,13]. At 
molecular level, EMT is characterized by the loss of epithelial markers such as E-cadherin, 
ZO-1, claudins, and acquisition of mesenchymal markers including N-cadherin, vimentin, 
Hic-5 and matrix metalloproteases (MMPs) [3,15]. To initiate the EMT program, signals are 
required that activate specific transcription factors (TFs) such as Snail, Slug, Zeb and Twist 
[13]. These TFs directly regulates genes involved in cell adhesion, polarity and cytoskeleton 
reorganization [16]. Overexpression of these TFs in epithelial cells induces either partial or 
complete changes from an epithelial to mesenchymal morphology, associated with increased 
motility, invasive capacity and resistance to chemotherapy [17–19]. In normal conditions, 
the epithelial cells maintains adherent junctions, where E-cadherin forms a complex with β-
catenin in the cell membrane [3,20]. During the EMT β-catenin translocates from the 
membrane to the nucleus where it establishes a complex with the TFs TCF/LEF. This 
complex induce the expression of EMT-related genes, by recognizing the consensus 
sequence T/A-CAAAG found in the HMG box in the promoter region of genes such as MYC, 
CCND1, SNAI1 and TWIST1 [21–23]. Among these, Twist is a 28 kDa, basic helix-loop-
helix (bHLH) domain-containing TF, with a fundamental role in cell invasion and cancer 
progression [24]. The known mechanism by which Twist favors cell migration and invasive 
capabilities of the cells is through the binding to the consensus sequence CANNTG of the 
CDH1 promoter to repress the expression of E-cadherin, leading to the loss of intercellular 
adhesions [25]. Twist is also necessary for the invadopodia formation [26].   
Cell invasion is a process associated to EMT, which requires the degradation of the 
extracellular matrix (ECM) by the tumor cell to allow its infiltration to the adjacent tissue 
[27]. To achieve this, one of the primary structures formed during the local invasion is the 
invadopodia, which are membrane protrusions rich in actin puncta [28,29]. The invadopodia 
formation is required for the local degradation of ECM components through the secretion 
and activation of MMP-2 and MMP-9, and MMP-14 [28–30]. MMP-2 and MMP-9 (also 
called gelatinase A and B, respectively) have been correlated with the invasive stage of 
carcinomas due to their ability to degrade gelatin and collagen type IV, the main components 
in the basal membrane [29,31]. Experimental evidence suggests that MMP-2 and MMP-9 
also contribute to the initiation and progression of breast cancer by cleaving and activating 
diverse proteins involved in angiogenesis, invasion and metastasis [32]. In addition, a high 
activity of MMP-2 and MMP-9 has been observed in serum and tissue of patients with breast 
cancer compared to healthy patients [33,34]. Several signaling pathways, such as WNT, 
PI3K/AKT, MAPK, JNK, focal adhesion kinase (FAK) and Src, are activated during the 
remodeling of the ECM [35]. Among these kinases, the secretion and activation of MMP-2 
and MMP-9 in breast cancer cell lines was shown to be dependent on cytosolic tyrosine 
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kinases Src [36–39], and FAK [40,41]. Both enzymes are necessary for proliferation, cell 
migration, invasion, and metastasis, at least in part for their participation in the regulation of 
the expression and activation of MMPs [38,40–42]. 
Previous reports using the non-tumorigenic breast epithelial cell line MCF10A demonstrated 
that leptin induces a partial EMT, where the cells change from an epithelial to a mesenchymal 
morphology [43]. This phenotype was characterized by a leptin-induced activation of FAK 
and ERK, which correlated with an increase in the expression of the intermediate filament 
vimentin, as well as the relocation of E-cadherin from membrane to cytoplasm [43]. These 
events favored the collective cell migration of MCF10A cells [43]. However, the mechanisms 
by which leptin activate diverse signaling pathways, and how the kinases contribute to EMT 
are not fully understood. Therefore, the aim of this research was to determine the role of Src 
and FAK in expression of EMT-related transcription factors and invasion in MCF10A cells 
stimulated with leptin. We found that leptin activates Src and FAK, leading to a variety of 
EMT-associated events, such as expression of EMT-related the TFs, Twist an -catenin, as 
well as MMPs secretion, invadopodia formation and invasion in the non-tumorigenic 
MCF10A epithelial cell line. This report provides insights on the signaling pathways 
operating downstream of the leptin-induced EMT, and their ultimate functional effectors 
which contributes to this process. 
2. Materials and Methods 
2.1 Materials 
Recombinant human leptin, FAK (PF-573228) and Src (PP2) inhibitors were obtained 
from Sigma-Aldrich (St Louis, MO, USA). Mouse anti-actin, rabbit anti-FAK and rabbit? anti-
Src antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Rabbit 
anti-GAPDH antibody was from Cell Signaling (Danvers, MA, USA). The phospho-specific 
antibody against FAK, rabbit anti-pY397, was obtained from Invitrogen (Carlsbad, CA, USA). 
The phospho-specific antibody against Src, rabbit anti-pY418, was obtained from 
MyBiosource (San Diego, CA, USA). The secondary HRP-conjugated antibodies were from 
Millipore (Billerica, MA, USA), and the anti-mouse and anti-rabbit conjugated with Alexa 
Fluor 488 antibodies were from Invitrogen (Carlsbad, CA, USA). TRITC conjugated 
phalloidin was purchased from Cytoskeleton (Denver, CO, USA). 
 
2.2 Cell culture 
The non-tumorigenic mammary epithelial cell line MCF10A (ATCC, VA, USA) was 
cultured in DMEM/F12 media (50:50, V:V; Sigma-Aldrich, St Louis, MO) supplemented with 
5% fetal bovine serum (FBS) and 1% antibiotics (penicillin G/Streptomycin, Gibco, Waltham, 
MA) in a humidified atmosphere containing 5% CO2 at 37 ºC. For experimental purposes, cell 
cultures were serum-starved for 4 h before treatment with either FAK or Src inhibitors and/or 
leptin. Cell cultures were used between passages 3-15. 
 
2.3 Cell stimulation 
MCF10A cell cultures were washed with PBS, and then treated with FAK (10 µM) or Src 
(10 µM) inhibitors and/or leptin for the times and concentrations indicated in the figure legends. 
Cell cultures were grown to confluence in 60 mm plates containing 3 mL of DMEM/F12 for 
each experimental condition. Cell stimulation was terminated by removing the medium, and 
solubilizing the cells in 0.5 mL of ice-cold radioimmune precipitation assay (RIPA) buffer, 
containing 50 mM HEPES pH 7.4, 150 mM NaCl, 1 mM EGTA, 1 mM sodium orthovanadate, 
100 mM NaF, 10 mM sodium pyrophosphate, 10% glycerol, 1% Triton X-100, 1% sodium 
deoxycholate, 1.5 mM MgCl2, 0.1% SDS and 1 mM phenylmethylsulfonyl fluoride (PMSF). 
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2.4 Western blot  
Whole cell lysates (20 µg) were resolved on 10% SDS-polyacrylamide gels and transferred 
to nitrocellulose membranes. To block non-specific binding the membranes were incubated in 
5% (w/v) non-fat dried milk in TBS/T (0.05% tween 20 in TBS) for 2 h at room temperature 
(RT). Membranes were then incubated with the primary antibodies, anti-Twist, anti-β-catenin, 
anti-actin, anti-pY397, anti-FAK, anti-pY418 and anti-Src overnight at 4 °C (1:1000 dilution). 
Next, the membranes were washed with TBS/T and incubate with HRP-conjugated antibodies 
(1:5000 dilution) for 2 h, at RT. Membranes were developed using an enhanced 
chemiluminescence detection system from Bio-Rad (Hercules, CA, USA).  
 
2.5 Immunofluorescence and F-actin staining 
MCF10A cells were seeded on glass coverslips, grown to 70% confluence, and stimulated 
either with or without leptin for 24 and 48 h. Cells were fixed for 5 min with 4% 
paraformaldehyde in PBS and permeabilized with 0.2% Triton-X100 in PBS at RT. For 
immunofluorescence (IF) assays, non-specific staining was blocked with 3% bovine serum 
albumin in PBS for 1 h at RT. Then, the cells were incubated 2 h at RT with the anti-Twist, 
anti-β-catenin antibodies (1:250 dilution), followed by a 2 h incubation at RT with an anti-
rabbit conjugated to Alexa Fluor 488 secondary antibody (1:400 dilution). For F-actin staining, 
cells were incubated with TRITC-conjugated phalloidin (1:1000 dilution) for 30 min at RT. 
Nucleus were counterstained with 4´6-diamidino-2-phenylindole and samples were mounted 
with Fluoroshield/DAPI media (Sigma-Aldrich, St Louis, MO, USA), and imaged with an 
Olympus BX43 microscope, using the 100X immersion objective. Images were analyzed with 
ImageJ software [44]. 
 
2.6 Gelatin zymograms 
To assess MMP-2 and MMP-9 activity, MCF10A cells were stimulated with leptin and/or 
kinases inhibitors for the time and concentrations indicated in the figure legends. The 
conditioned medium was collected and concentrated using 30 kDa cutoff ultra-centrifugal filter 
units (Amicon, Merck-Millipore, MA). Protein concentration was determined by Bradford 
method [45], and 20 µg of concentrated supernatant of each condition were assayed for 
proteolytic activity on gelatin-substrate gels [46]. Briefly, samples were mixed with non-
reducing buffer containing 2.5% SDS, 1% sucrose and 4 mg/mL phenol red, and separated in 
8% acrylamide gels co-polymerized with 1 mg/mL gelatin, as previously described [20]. After 
electrophoresis at 72 V for 2.5 h, the gels were rinsed twice in 2.5% Triton X-100, and then 
incubated in 50 mM Tris–HCl pH 7.4 and 5 mM CaCl2 assay buffer at 37 °C for 24 h. Gels 
were fixed and stained with 0.25% Coomassie Brilliant Blue G-250 in 10% acetic acid and 
30% methanol. Proteolytic activity was detected as clear bands against the background stain of 
undigested substrate in the gel. Quantification was performed using ImageJ software [44].  
 
2.7 Invadopodia formation assays 
MCF10A cells were treated with leptin 400 ng/mL and then seeded in coverslips that were 
previously treated for invadopodia formation assays, as described [47]. Briefly, the coverslips 
were incubated with 20% sulfuric acid overnight and sterilized with 96% ethanol. Then, the 
coverslips were covered with 50 μg/mL of poly-L-Lysine diluted in PBS, followed by a 
treatment with 0.5% glutaraldehyde in PBS, and a final incubation with 0.2% gelatin solution 
in PBS at 37 °C for 30 min. Pre-treated MCF10A cells were cultured for 6 h in serum 
supplemented medium. The cells on the coverslips were fixed and permeabilized with 4% 
formaldehyde/0.5% Triton X-100 in PBS, blocked with 3% BSA and incubated with 
phalloidin-TRITC for 30 min at 37 °C, coverslips were mounted using Fluoroshield/DAPI 
media and finally visualized in a Olympus BX43 microscope, using the 100X immersion 
objective. Images were analyzed with Image J software. 
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2.8 Cell Invasion assays 
Matrigel invasion assays were performed following the transwell chamber method [48], 
using 24 well plates containing inserts of 8 m pore size (Corning Inc, Kennebunk, ME). 
Briefly, 30 µL of Matrigel (Corning) was added into the inserts and kept at 37 °C for 30 min 
to form a semisolid matrix. Untreated or treated cells with FAK or Src inhibitors were plated 
at 1x105 cells per insert in serum-free medium on the top chamber. The lower chamber of the 
transwell contained 600 µl DMEM supplemented or not with leptin 400 ng/mL. Cells were 
incubated for 48 h at 37 °C in a 5% CO2 atmosphere. Following incubation, cells and Matrigel 
on the upper surface of the transwell membrane were gently removed with cotton swabs. 
Invading cells on the lower surface of the membrane were washed and fixed with methanol for 
5 min, and stained with 0.1% crystal violet diluted in PBS. Cell quantification was performed 
using a hemocytometer, and an Olympus BX43 microscope with the 100X objective. 
 
2.9 Statistical analysis 
Results are expressed as the mean ± SD. Data was statistically analyzed using one-way 
ANOVA and the comparisons were performed using Newman-Keuls and Dunette multiple 
comparison tests. Statistical probability of p <0.05 was considered significant. 
3. Results 
3.1 Leptin induces FAK and Src activation in MCF10A non-tumorigenic epithelial breast 
cells 
Kinase activation is a fundamental process for cancer progression and metastasis [49,50]. 
Src and FAK activation is triggered by the autophosphorylation at Y418 and Y397, 
respectively [49,51,52]. Emerging evidence from our lab and others showed that these 
kinases may also contribute to early events during EMT [53–56]. Furthermore, we reported 
previously that leptin induces the activation of FAK, and in consequence a partial EMT was 
detected in MCF10A cells [43]. In this work we further explored whether leptin induces the 
activation of FAK and Src in MCF10A cells, and how these kinases were associated to the 
expression of the downstream EMT-related TFs, Twist -catenin. Therefore, we 
initiated our studies by analyzing the activation of Src and FAK, as both kinases are 
associated to the induction of Twist and -catenin [57,58]. To this end, MCF10A cultures 
were stimulated with leptin 400 ng/mL and protein extracts were obtained at different time 
points for Western blot analyses of Src and FAK activation. Figure 1 shows that leptin 
induces Src phosphorylation in Y418 between 15-30 min of stimulation (Fig. 1A, C), while 
FAK Y397 phosphorylation occurs within 10-15 min (Fig. 1B, D), consistent with our 
previous report [43]. These data suggest that FAK and Src, two kinases involved in cell 
proliferation and migration are activated by leptin. 
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Figure 1. Leptin activates Src and FAK in the non-tumorigenic breast epithelial cell line MCF10A. 
Representative Western blots of whole cell extracts obtained at different time points from MCF10A 
cells stimulated with 400 ng/mL of leptin. A) Effect of leptin in Src activation was detected with an 
anti-p-Y418 antibody and was compared to total Src. B) Effect of leptin in FAK activation was 
detected with an anti-p-Y397 antibody and was compared to total FAK. GAPDH was used as loading 
control. Densitometric analyses of Src C) and FAK D) phosphorylation dependent on leptin. The 
values are shown in means ±SD of three independent experiments and are expressed as changes with 
respect to the control (unstimulated cells). The asterisks indicate the comparison made with respect to 
the control. * p <0.05, ** p <0.01 and *** p <0.001 by one-way ANOVA (Dunnett´s test). 
3.2 Leptin regulates the expression and subcellular localization of Twist and β-catenin in 
MCF10A epithelial breast cells 
Twist and -catenin are TFs that play an important role during EMT, tumor progression, 
chemoresistance, and cancer stem cell (CSC) maintenance [59–61]. Importantly, leptin 
induces the expression of Twist and β-catenin in breast cancer cells [9,10]. Therefore, we 
evaluated whether leptin induces the expression of these two TFs in a cellular model of non-
tumor mammary epithelium. To determine the expression and subcellular localization of 
Twist and -catenin in MCF10A cells stimulated with leptin, Western blot and 
immunofluorescence analyses were performed. An early maximum peak of Twist expression 
was detected after 3 h of leptin treatment, which gradually decreased at 12 h and was lost 
after 48 h of the stimulus (Fig. 2A). Quantification and statistical analyses of the Western 
blots (Fig. 2B), as well as epifluorescence microscopy imaging (Fig. 2D) confirmed these 
results, and demonstrated that Twist is largely located in the nucleus at all times tested. 
Conversely, β-catenin expression in MCF10A cells stimulated with leptin remained stable 
during the first 24 h of treatment (Fig. 2A, C). β-catenin was induced after 48 h of leptin 
stimulus, as corroborated by statistical analyses. IF analyses showed that β-catenin is located 
at the cell membrane in unstimulated cells. Interestingly, within 3 h of treatment, β-catenin 
is predominantly located in the nucleus. After 6 h of leptin treatment β-catenin seems to 
acquire an equilibrium state between the cell membrane and the nucleus, being 
predominantly located at the membrane; this equilibrium is lost after 48 h when β-catenin 
returns to the nucleus (Fig. 2E). This data strongly suggest that leptin induce an early 
activation and nuclear translocation of Twist and β-catenin, and may act as TF of EMT-
associated events. 
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Figure 2. Leptin induces the expression of EMT-related transcription factors, Twist and β-catenin in 
MCF10A cells. MCF10A cells were treated with leptin 400 ng/mL for different times and the 
expression and localization of Twist and β-catenin was analyzed. A) Representative Western blot of 
Twist and β-catenin. Β-actin was used as loading control. Densitometric and statistical analysis of the 
bands obtained by Western blot for Twist (B) and β-catenin (C); the values are shown in means ± SD 
of three independent experiments, and are expressed as changes respect to the control (unstimulated 
cells). The asterisks indicate the comparison made with respect to the control. *** p <0.001 by one-
way ANOVA (Dunnett´s test). Representative immunofluorescence microscopy images showing in 
green, the expression of Twist (D) and β-catenin (E), the nucleus was counterstained with DAPI; 
images were acquired using the 100X magnification. 
3.3 Leptin regulates the expression and subcellular localization of Twist and β-catenin 
in a Src and FAK-dependent manner in MCF10A cells 
Twist and β-catenin are downstream effectors of different kinases and signaling 
pathways [24]. We focused on the effect of Src and FAK in the activation of these TFs, as 
both kinases are associated to EMT-related events [15,43,51]. To address this, we took 
advantage of the specific Src and FAK inhibitors, PP2 or PF-573228, respectively. MCF10A 
cells were pre-treated with either inhibitor, and then stimulated with leptin for 24 and 48 h. 
Western blot and IF analyses showed that in the presence of the Src inhibitor (PP2) the leptin-
dependent increase observed for the two TFs, Twist and β-catenin, was abolished (Fig. 3A-
C, G). These data suggest that leptin may exert its effect in the activation of these TFs, at 
least partially, via Src signaling pathway. On the other hand, the inhibitor for FAK (PF-
572238) only had an inhibitory effect on the leptin-induced expression of Twist, as this TF 
was expressed at similar levels observed in non-treated control cells (Fig. 3D, E, H). No 
changes in the levels of expression of β-catenin induced by leptin were observed upon FAK 
inhibition (Fig. 3D, F). Moreover, the leptin-induced nuclear distribution of β-catenin was 
maintained in the presence of the FAK inhibitor (Fig. 3H). These data suggest that FAK 
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signaling may be involved in the expression and transcriptional activation of Twist, but not 




Figure 3. Src and FAK regulate the expression and subcellular localization of Twist and β-catenin. 
MCF10A cells were pre-treated with Src (PP2) or FAK (PF-573228) inhibitors, and subsequently with 
(leptin 400 ng/mL). A) Representative Western blot of Twist and β-catenin expression upon Src 
inhibition. Densitometric analyses of B) Twist and C) β-catenin expression upon Src inhibition. D) 
Representative Western blot of Twist and β-catenin expression upon FAK inhibition. Densitometric 
analyses of E) Twist and F) β-catenin expression upon FAK inhibition. Β-actin was used as loading 
control. The values represent the mean ± SD of three independent experiments and are expressed as 
changes with respect to the control (unstimulated cells). The asterisks indicate the comparison made 
with respect to the control. * p<0.05 and *** p<0.001 by one-way ANOVA (Newman-Keuls’s test). 
Representative images of epifluorescence microscopy using 40X magnification. MCF10A cells were 
pre-treated with PP2 and PF-573228 and subsequently stimulated with leptin (400 ng/mL). The 
subcellular localization of G) Twist and H) β-catenin is shown in green, and in blue the DNA was 
counterstained with DAPI. 
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3.4 Leptin induces MMP-2 and MMP-9 secretion in a Src- and FAK-dependent fashion in 
MCF10A cells 
MMPs are a family of endopeptidases capable to degrade the ECM components, thus 
they are fundamental players for tumor progression, by promoting invasion through the 
basement membrane and interstitial matrix, angiogenesis, and growth of tumor cells [62,63]. 
MMP-2 and MMP-9 expression is elevated in malignant tumors and largely contribute to the 
ability of tumor cells to metastasize, as they efficiently degrade collagen type IV, which is 
the main component of the basement membrane [64]. To date, little information is available 
about the regulation of MMP-2 and MMP-9 expression and secretion during EMT [65], and 
less is our knowledge on how leptin mediates this process. Therefore, to determine whether 
leptin induces the MMP-2 and MMP-9 secretion and activation, gelatin zymograms were 
performed. The MCF10A cells were treated with increasing concentrations of leptin for 24 h 
(Fig. 4A), the supernatant was collected, concentrated and 20 µg of protein were used to 
assay activity of both MMPs. Densitometric and statistical analyses, demonstrated that 400 
ng/mL of leptin induced the highest level of activation of both MMPs (Fig. 4B, C). Therefore, 
we chose this concentration for further experimentation, and treated the cells for different 
times (Fig. 4D-F). In this instance, we detected that activity of both MMPs further increased 
after 6 h of leptin treatment (Fig. 4D). It is noteworthy that MMP-2 activation was greater 
than MMP-9. Then, to establish whether the Src and FAK regulate the secretion of MMP-2 
and MMP-9, the inhibitors PP2 and PF-573228 were used. Zymograms showed that 
inhibition of both kinases impaired the leptin-induced activation of MMP-2 and MMP-9; 
densitometric analyses of three independent biological replicates confirmed that the 
inhibitory effect was statistically significant (Fig. G-L). These data suggest that the leptin-
induced activation of MMP-2 and MMP-9 relies in the Src and FAK signaling pathways. 
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Figure 4. Leptin promotes invasion-related processes by activating MMPs in a Src- and FAK 
dependent manner in MCF10A cells. MCF10A cells were treated with leptin 400 ng/mL for different 
times and MMP activity by degradation of bovine gelatin as a specific substrate was evaluated. A) 
Representative zymogram gel from culture supernatants of MCF10A cells treated with increasing 
concentrations of leptin corresponding to the degradation bands of MMP-9 (92 kDa) and MMP-2 (72 
kDa). The plots represent the densitometric and statistical analysis of the bands obtained by gelatin 
zymography shown for B) MMP-9, and C) MMP-2. D) Representative zymogram gel from culture 
supernatants of MCF10A cells treated with 400 ng/mL of leptin for different times corresponding to 
the degradation bands of MMP-9 and MMP-2. The plots represent the densitometric and statistical 
analysis of the bands obtained by gelatin zymography shown for B) MMP-9, and C) MMP-2. The 
values are shown in means ±SD of three independent experiments and are expressed as changes with 
respect to the control (unstimulated cells). The asterisks indicate the comparison made with respect to 
the control. * p <0.05, ** p <0.01 and *** p <0.001 by one-way ANOVA (Dunnett´s and Newman-
Keuls test). 
 
3.5 Leptin induce the formation of stress fibers in a Src- and FAK-dependent manner in 
MCF10A cells 
Stress fibers are essential for cell motility and maintenance of structure [66]. The 
remodeling of actin filaments during EMT is essential necessary [67]. Our group and others 
have shown that during leptin-induced EMT of MCF10A cells [43], and in several cancer 
.CC-BY-NC 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/739169doi: bioRxiv preprint first posted online Aug. 18, 2019; 
 
cell lines [51,68,69], this hormone promotes the formation of stress fibers [70,71]. However, 
understanding of how this process is regulated is still limited. We then asked whether the 
leptin-induced activation of the kinases Src and FAK had an effect in the formation of stress 
fibers in MCF10A cells. First, we verified that leptin indeed promoted the formation of stress 
fibers, as expected the leptin treated cells treated with leptin 400 ng/mL more and thicker 
actin filaments with a linear distribution, compared to the less and circular fibers observed in 
non-treated control cells (Fig. 5A, B [43]. This leptin induced-effect was abolished in 
MCF10A cells that were pre-treated with the Src (PP2, Fig. 5A), but not with the FAK (PF-
573228) inhibitor (Fig. 5B). We showed previously that leptin treatment induces a 
morphological change from a cuboid epithelial morphology to an enlarged mesenchymal 
phenotype in MCF10A cells [43]. We observed that treatment with inhibitors for both kinases 
prevented the morphological changes observed with leptin alone (Fig. 5). These data suggests 
that cytoskeleton modifications during EMT may rely in the activation of these two kinases. 
3.6 Leptin induces invadopodia formation in a FAK and Src-dependent pathway in MCF10A 
cells 
Invasive properties of the cells correlate with a dynamic membrane structure rich in actin 
[72]. These structures are membrane protrusions called invadopodia, and function as matrix 
adhesion sites [73], possess the ability to degrade the ECM components, and are 
characteristic of invasive tumor cells [74]. An actin-core is formed during initial steps of 
invadopodia assembly, which acquires a perpendicular distribution to the ECM and the 
membrane and can be frequently observed as actin puncta [75]. Considering the effect that 
leptin excreted in the actin cytoskeleton (Fig. 5), we sought to determine whether leptin is 
also capable to induce the invadopodia formation in MCF10A cells. Therefore we performed 
in vitro invadopodia formation assays, using Alexa Fluor 488-labeled gelatin assays, which 
allow to detect both, the presence of invadopodia and their activity using fluorescence 
microscopy [76]. Our results show that control cells do not present actin puncta, and are 
unable to degrade the gelatin matrix (Fig. 5C). However, upon leptin treatment, the cells 
presented actin puncta formation which colocalized with areas of gelatin degradation 
(observed as black dots, indicated by white arrows; Fig. 5C).  
 
Figure 5. Leptin stimulation leads to the re-arrangement of the actin cytoskeleton and formation of 
invadopodia. Representative images of MCF10A cells pre-treated or not with PP2 (A) or PF-573228 
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(B) for 30 min and subsequently with leptin (400 ng/mL) for 24 h. Actin filaments were detected with 
Phalloidin-TRITC (red) and DNA was counterstained with DAPI. Images were acquired using the 
40X magnification. C) Representative images of invadopodia formation assays. Actin puncta was 
detected with phalloidin (red) and Alexa 488-labeled gelatin (green) was used as a specific substrate 
for the membrane-bound MMP-14 located at the edge of invadopodia. Arrows indicate areas of gelatin 
degradation. Images were acquired using a 100X magnification.  
We observed that Src had an effect in the formation of thick stress fibers (Fig. 5A), whereas 
FAK appeared to be not essential in this process (Fig. 5B). However, both kinases appeared 
to be relevant for the leptin-induced morphological changes observed in MCF10A cells. 
Thus, we hypothesized that both kinases may be also be involved in invadopodia formation, 
as this structure contributes largely to the morphological and migratory phenotypes that 
emerge during EMT [77,78]. Therefore, to determine the role of Src and FAK in the 
invadopodia formation in MCF10A cells stimulated with leptin, we performed similar gelatin 
degradation experiments in the presence and absence of the kinases’ inhibitors. Our results 
show the actin puncta formation and an increase in the degradation of gelatin in leptin-treated 
cells, indicative of invadopodia formation (Fig. 6). When the cells were treated with either 
Src-, or the FAK-specific inhibitors, actin puncta formation and gelatin degradation was not 
observed (Fig. 6). Is noteworthy that MMP-14 is a predominant transmembrane protease 
activated in the regions where invadopodia is formed [79]; thus we cannot overrule the 
possibility that both kinases also promotes the activation of MMP-14 in a leptin-dependent 
manner.  
 
Figure 6. Src and FAK regulate the invasion capacity of MCF10A cells stimulated with leptin. 
Representative images of MCF10A cells pre-treated or not with PP2 or PF-573228 (10 µM) for 30 
min and subsequently incubated in the presence or absence of leptin (400 ng/mL) for 24 h. Actin 
puncta was detected with phalloidin (red) and Alexa 488-labeled gelatin (green) was used as a specific 
substrate for the membrane-bound MMP-14 located at the edge of invadopodia. Arrows indicate areas 
of gelatin degradation. Images were acquired using a 100X magnification.  
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3.6 Leptin induces cell invasion in a Src-dependent pathway in MCF10A cells 
At this point, we have evidence of the requirement of Src and FAK in the secretion and/or 
activation of at least three MMPs relevant for EMT. Previously, our group showed that FAK 
is necessary for the acquisition of enhanced migratory capabilities driven by leptin in 
MCF10A cells [43]. Therefore, here we evaluated the contribution of Src in cell invasion in 
MCF10A cells stimulated with leptin. Invasion assays were performed in transwell chambers 
[48], with MCF10A cells that were treated or not with leptin and PP2. Figure 7 shows that 
control cells have reduced mobility, and are not capable to colonize the matrix in the 
transwell, while leptin-treated cells were capable to invade this area. As expected, Src 
appeared to be an essential kinase in this process, as the leptin-induced invasion properties 
of MCF10A cells treated with PP2 was ablated. These data suggest that Src is a relevant 




Figure 7. Leptin induce invasion in MCF10A cells in a Src-dependent manner. A) Representative 
light microscopy images of invasion assays of MCF10A cells grown in the presence or absence of 
leptin and the Src inhibitor PP2. B) Quantitative analyses of the invasion assays presented in A); the 
values represent the mean ± SD of three independent experiments, and are expressed as changes with 
respect to the control (unstimulated cells). The asterisks indicate the comparison made with respect to 
the control.  *** p <0.001 by one-way ANOVA (Dunnett´s test). 
4. Discussion 
EMT is a reversible cellular process by which epithelial cells undergo trans-differentiation 
events from an epithelial to a mesenchymal phenotype in where EMT-related transcription 
factors are key molecules [3]. EMT is also associated with tumor progression and the invasive 
and metastatic phenotype in cancer cells [14]. Here, we studied leptin, a hormone primarily 
secreted by adipocytes, which is also secreted, in lesser extent, in normal and tumorigenic 
mammary tissue [80,81]. Several studies have established the association between 
overexpression of leptin and its receptor, ObR, during breast cancer progression [4–6]. 
Expression and hyperactivation of various molecules (kinases, TFs, MMPs, adhesion 
proteins) are associated with the activation of the EMT program, a couple of examples are 
the kinases Src and FAK [82]. In this study, we evaluated the effect of leptin in the activation 
of these kinases in the regulation of EMT-related TFs and for invasion-related processes in 
the non-tumorigenic mammary epithelial cell line MCF10A. Src and FAK activation was 
evaluated through the phosphorylation levels at Y418 and Y397, respectively, in MCF10A 
cells stimulated with leptin 400 ng/mL. Our results showed early maximal activation peaks 
for both kinases within 10-15 min of leptin stimulation. These data is consistent with our 
previous report, where leptin induced the activation of FAK between 10-30 min of 
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stimulation in MCF10A, MCF7 and MDA-MB-231 cells [43,51]. However, the mechanism 
by which leptin activates Src and FAK in MCF10A remain unclear, and several alternatives 
should be explored in the future. For instance, in circulating angiogenic cells, leptin induces 
Src activation through the αvβ5 integrins pathway [83]. Likewise, in the colon 
adenocarcinoma SW480 cell line, FAK activation induced by leptin is also dependent on 
integrins activation [84]. In contrast, in MDA-MB-231 cells Src activation is SHP2-
dependent which binds to the phosphorylated Y985 of the ObR receptor [85]. Therefore, 
further studies should be directed to elucidate the mechanism of activation of both kinases in 
response to leptin in the MCF10A epithelial cell line. 
The EMT program activation is regulated by specific TFs such as Twist and -catenin, which 
are associated with cell invasion and metastasis [13,14]. In this study, we showed that leptin-
induced Twist expression is an early event that may contribute to the initial establishment of 
EMT, which is in agreement with studies performed in the breast cancer cell lines MCF7 and 
SK-BR-3, where leptin also induced the expression of this TF [9,10]. Here, we demonstrated 
that Twist expression and localization is regulated in a Src- and FAK-dependent manner. 
These novel activation pathways for Twist contribute to our understanding of the signaling 
and transcriptional events associated to this factor during leptin-induced EMT. For instance, 
it is well known that in MDA-MB-231 cells, Src induces STAT3 activation, a TF that 
regulates the TWIST1 expression [58]. Leptin also activates STAT3 in a JAK2-dependent 
manner, and allows its dimerization and nuclear translocation where it regulates the 
expression of the TWIST1 gene [86,87]. In PCa cells, which are from prostate origin, but 
derived from their metastatic site, the bone, the inhibition of FAK decreased the activation 
of the Hypoxia-inducible factor 1-α (HIF-1α), which also regulates TWIST1 [88]. 
Furthermore, β-catenin, whose primary function is to maintain adherent junctions by 
interacting with E-cadherin, α-catenin and the actin cytoskeleton regulating cell-cell contact. 
-catenin can be relocated into the nucleus where acts as a transcription factor 
forming complexes with DNA binding proteins such as TCF/LEF [89,90]. In this study, we 
observed that β-catenin expression increases in leptin-stimulated cells in addition to a nuclear 
relocation of β-catenin at 3 h. These findings might be related to the decrease in the 
expression or changes in the location of proteins at adherent junctions, particularly, E-
cadherin and β-catenin plays an important role in the induction of EMT [91]. The 
overexpression of both TFs and their nuclear location could be related to the gene expression 
of the EMT markers, suggesting that leptin induces EMT-related processes such as MMPs 
expression and activation as well as invasion in mammary epithelial cells MCF10A. 
Overexpression of Twist and β-catenin is associated with EMT and invasiveness [92–94]. 
Actin re-organization and the formation of stress fibers are essential events for cell migration, 
and are considered the hallmark of EMT [95,96]. Studies have shown that leptin induces 
remodeling of the cytoskeleton and morphological changes in mammary epithelial cells 
[43,71], and in MDA-MB-231 breast cancer cells FAK and Src regulate the formation of 
stress fibers [97]. We demonstrated that leptin induces the formation of stress fibers in a Src-
dependent manner, and that both kinases contributed to the morphological changes observed 
upon leptin treatment. One of the functional consequences of EMT is invasion, which 
initiates with invadopodia formation promoting the local degradation of ECM, through the 
recruitment of MMPs, such as MMP-2 and MMP-9, and MMP-14 [75,98,99]. In our study, 
we observed that leptin induces the expression, secretion and activation of these MMPs, and 
promotes the invadopodia formation in a Src- and FAK-dependent manner. In cellular models 
of breast cancer, both, MMP-2 and MMP-9, participate in invasion, metastasis and 
angiogenesis [32]. A study conducted in multiple tumor cell lines showed that the expression 
of MMP-9 is regulated by the FAK-ERK1/2-Akt pathway, through the regulation of p65 and 
c-Fos [100]. While in SW480 cells the expression of MMP-2 is dependent on the FAK/Src 
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and ERK1/2 pathways [101]. Similarly, a study conducted in the A549 human non-small-cell 
lung carcinoma cell line, FAK-Src, ERK1/2 kinases, and β-catenin regulate the expression 
of MMP-2 and MMP-9 [102]. 
5. Conclusions 
Our results demonstrate that leptin induces the activation of Src and FAK, which in turn 
regulate the expression of the EMT-related TFs β-catenin and Twist. Morphological 
remodeling and invadopodia formation, as well as MMPs secretion and activation, appear to 
be also effectors of leptin-induced EMT. All together, these EMT markers play a key role 
during cell invasion of tumor cells (Fig. 8). 
 
Figure 8. Model for leptin-induced EMT via Src and FAK signaling pathways 
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